$3.83
-0.06-1.54%
al cierre: -
$3.88
0.051.27%
After hour: Oct 17, 7:29 PM EDT
Altimmune informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Altimmune utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ALT | Altimmune | -$0.32 | -$0.28 | — | — | $5.00K | $560.00 | — | — | 11/11/2025 | |
ALT | Altimmune | -$0.35 | -$0.32 | -$0.27 | 15.62% | $5.00K | $560.00 | $5.00K | 792.86% | 08/12/2025 | |
ALT | Altimmune | -$0.34 | -$0.35 | -$0.26 | 25.71% | $5.00K | — | $5.00K | — | 05/13/2025 | |
ALT | Altimmune | -$0.54 | -$0.34 | -$0.33 | 2.94% | $37.00K | — | $5.00K | — | 02/27/2025 | |
ALT | Altimmune | -$0.39 | -$0.35 | -$0.32 | 8.57% | $362.00K | — | $5.00K | — | 11/12/2024 | |
ALT | Altimmune | -$0.32 | -$0.34 | -$0.35 | -2.94% | $6.00K | — | $5.00K | — | 08/08/2024 | |
ALT | Altimmune | -$0.40 | -$0.37 | -$0.34 | 8.11% | $21.00K | — | $5.00K | — | 05/09/2024 | |
ALT | Altimmune | -$0.43 | -$0.43 | -$0.33 | 23.26% | -$110.00K | — | $37.00K | — | 03/27/2024 | |
ALT | Altimmune | -$0.48 | -$0.42 | -$0.39 | 7.14% | $2.00K | — | $362.00K | — | 11/07/2023 | |
ALT | Altimmune | -$0.42 | -$0.46 | -$0.32 | 30.43% | $8.00K | — | $6.00K | — | 08/10/2023 | |
ALT | Altimmune | -$0.44 | -$0.48 | -$0.40 | 16.67% | $32.00K | — | $21.00K | — | 05/11/2023 | |
ALT | Altimmune | -$0.57 | -$0.50 | -$0.43 | 14.00% | $3.28M | $30.00K | -$110.00K | -466.67% | 02/28/2023 | |
ALT | Altimmune | -$0.81 | -$0.50 | -$0.48 | 4.00% | $200.00K | $870.00K | $2.00K | -99.77% | 11/10/2022 | |
ALT | Altimmune | -$0.41 | -$0.51 | -$0.42 | 17.65% | $137.62K | $870.00K | $8.00K | -99.08% | 08/11/2022 | |
ALT | Altimmune | -$0.38 | -$0.58 | -$0.44 | 24.14% | $837.52K | $1.03M | $32.00K | -96.89% | 05/12/2022 | |
ALT | Altimmune | -$0.17 | -$0.65 | -$0.57 | 12.31% | $2.31M | $90.00K | $3.28M | 3542.22% | 03/15/2022 | |
ALT | Altimmune | -$0.54 | $0.39 | -$0.81 | -307.69% | $2.94M | $60.00K | $200.00K | 233.33% | 11/09/2021 | |
ALT | Altimmune | -$0.94 | -$0.50 | -$0.41 | 18.00% | $721.64K | $1.84M | $137.62K | -92.52% | 08/10/2021 | |
ALT | Altimmune | -$0.26 | -$0.47 | -$0.38 | 19.15% | $2.21M | — | $837.52K | — | 05/17/2021 | |
ALT | Altimmune | -$0.25 | -$0.75 | -$0.17 | 77.33% | $575.80K | $2.14M | $2.31M | 8.08% | 02/25/2021 | |
ALT | Altimmune | -$0.74 | -$0.76 | -$0.54 | 28.95% | $643.98K | $1.05M | $2.94M | 179.81% | 11/09/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-12 | $-0.27 | $-0.32 | 15.6 % |
Q1 | 2025-05-13 | $-0.26 | $-0.35 | 25.7 % |
Q4 | 2025-02-27 | $-0.33 | $-0.34 | 2.94 % |
Q3 | 2024-11-12 | $-0.32 | $-0.35 | 8.57 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-12 | $5.00K | $560.00 | 792.9 % |
Q4 | 2023-02-28 | $-110.00K | $30.00K | -466.7 % |
Q3 | 2022-11-10 | $2.00K | $870.00K | -99.8 % |
Q2 | 2022-08-11 | $8.00K | $870.00K | -99.1 % |
Está previsto que Altimmune (ALT) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 12, 2025 para el Q2.
El BPA real fue de $-0.27, que superó la estimación de $-0.32.
Los ingresos reales fueron $5K, que superó la estimación de $0.6K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.